東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cancer and the LGBT community = uniq...

Boehmer, Ulrike.

FindBook

Google Book

Amazon

博客來

Cancer and the LGBT community = unique perspectives from risk to survivorship /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Cancer and the LGBT community/ edited by Ulrike Boehmer, Ronit Elk.
其他題名:	unique perspectives from risk to survivorship /
其他作者:	Boehmer, Ulrike.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	xvii, 331 p. :ill., digital ;24 cm.
內容註:	Forward -- Introduction -- I Understanding and Reducing the Risk for Cancer -- Risk for Cancer in Gay, Bisexual and Transgender Men via Infection -- Understanding and Reducing Risks via Infection in LBT Women -- Addressing Behavioral Cancer Risks from a LGBT Health Equity Perspective -- Smoking in the LGBT Community -- II Screening for Cancer in LGBT populations -- Cancer screening in Lesbian and Bisexual Women and Trans Men -- Cancer screening in Gay and Bisexual Men and Transgender People PART III: Cancer Survivorship -- What are the numbers? Epidemiology of Cancer in the LGBT community -- Breast Cancer in Lesbian and Bisexual Women -- Gay Men and Prostate Cancer: Opportunities To Improve HRQOL and Access To Care -- HIV-Associated Cancers -- Provider-Patient Issues for the LGBT Cancer Patient -- Needs of LGBT Cancer Survivors -- Challenges and Recommended Solutions for Receiving Appropriate End-Of-Life-Care for Lesbians, Gay, Bisexual and Transgender Patients Diagnosed with Cancer with a Life-Limiting Prognosis -- IV Cancer at the Intersection -- Cancer Care needs of Transgender, Transsexual and other Gender Nonconforming Populations -- The Needs of Racial/Ethnic LGBT Individuals across the Cancer Care Continuum -- V Healthcare Policy and LGBT Health -- Policy and its Impact on LGBT Cancer -- Current policy and research on cancer in LGBT communities internationally -- The Challenges Remain: Needed Next Steps in Alleviating the Burden of Cancer in the LGBT Community -- Contributors -- Index.
Contained By:	Springer eBooks
標題:	Cancer - Epidemiology. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-15057-4
ISBN:	9783319150574 (electronic bk.)

Cancer and the LGBT community = unique perspectives from risk to survivorship /
Cancer and the LGBT communityunique perspectives from risk to survivorship /[electronic resource] :edited by Ulrike Boehmer, Ronit Elk. - Cham :Springer International Publishing :2015. - xvii, 331 p. :ill., digital ;24 cm.

Forward -- Introduction -- I Understanding and Reducing the Risk for Cancer -- Risk for Cancer in Gay, Bisexual and Transgender Men via Infection -- Understanding and Reducing Risks via Infection in LBT Women -- Addressing Behavioral Cancer Risks from a LGBT Health Equity Perspective -- Smoking in the LGBT Community -- II Screening for Cancer in LGBT populations -- Cancer screening in Lesbian and Bisexual Women and Trans Men -- Cancer screening in Gay and Bisexual Men and Transgender People PART III: Cancer Survivorship -- What are the numbers? Epidemiology of Cancer in the LGBT community -- Breast Cancer in Lesbian and Bisexual Women -- Gay Men and Prostate Cancer: Opportunities To Improve HRQOL and Access To Care -- HIV-Associated Cancers -- Provider-Patient Issues for the LGBT Cancer Patient -- Needs of LGBT Cancer Survivors -- Challenges and Recommended Solutions for Receiving Appropriate End-Of-Life-Care for Lesbians, Gay, Bisexual and Transgender Patients Diagnosed with Cancer with a Life-Limiting Prognosis -- IV Cancer at the Intersection -- Cancer Care needs of Transgender, Transsexual and other Gender Nonconforming Populations -- The Needs of Racial/Ethnic LGBT Individuals across the Cancer Care Continuum -- V Healthcare Policy and LGBT Health -- Policy and its Impact on LGBT Cancer -- Current policy and research on cancer in LGBT communities internationally -- The Challenges Remain: Needed Next Steps in Alleviating the Burden of Cancer in the LGBT Community -- Contributors -- Index.

Cancer and the LGBT Community: Unique Perspectives from Risk to Survivorship covers the scope of current knowledge of cancer in the LGBT community across the entire cancer continuum, from understanding risk and prevention strategies in LGBT groups, across issues of diagnosis and treatment of LGBT patients, to unique aspects of survivorship and death and dying in these communities. Each chapter includes an in depth analysis of the state of the science, discusses the many remaining challenges and unanswered questions, and makes recommendations for research, policy and programmatic strategies required to address these. Focus is also placed on the diversity of the LGBT communities. Issues that are unique to cancer in LGBT populations are addressed including the social, economic, and cultural factors that affect cancer risk behaviors, barriers to screening, utilization of health care services, and legislation that directly impacts the health care of LGBT patients, healthcare settings that are heterosexist, and unique aspects of patient-provider relationships such as disclosure of sexual orientation, and the need for inclusion of expanded definition of family to include families of choice. The implications of policy change, its impact on healthcare for LGBT patients are highlighted, as are the remaining challenges that need to be addressed. A roadmap for LGBT cancer prevention, detection, diagnosis, survivorship, including treatment and end of life care is offered for future researchers, policy makers, advocates and health care providers.

ISBN: 9783319150574 (electronic bk.)

Standard No.: 10.1007/978-3-319-15057-4doiSubjects--Topical Terms:

832876
Cancer
--Epidemiology.

LC Class. No.: RC281.S49

Dewey Class. No.: 616.994

Cancer and the LGBT community = unique perspectives from risk to survivorship /
LDR:04079nam a2200313 a 4500 001 2007410
003 DE-He213
005 20160111101909.0
006 m d
007 cr nn 008maaau
008 160219s2015 gw s 0 eng d
020 $a 9783319150574 (electronic bk.)
020 $a 9783319150567 (paper)
024 7 $a 10.1007/978-3-319-15057-4 $2 doi
035 $a 978-3-319-15057-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC281.S49
072 7 $a MBGR $2 bicssc
072 7 $a MED000000 $2 bisacsh
082 0 4 $a 616.994 $2 23
090 $a RC281.S49 $b C215 2015
245 0 0 $a Cancer and the LGBT community $h [electronic resource] : $b unique perspectives from risk to survivorship / $c edited by Ulrike Boehmer, Ronit Elk.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xvii, 331 p. : $b ill., digital ; $c 24 cm.
505 0 $a Forward -- Introduction -- I Understanding and Reducing the Risk for Cancer -- Risk for Cancer in Gay, Bisexual and Transgender Men via Infection -- Understanding and Reducing Risks via Infection in LBT Women -- Addressing Behavioral Cancer Risks from a LGBT Health Equity Perspective -- Smoking in the LGBT Community -- II Screening for Cancer in LGBT populations -- Cancer screening in Lesbian and Bisexual Women and Trans Men -- Cancer screening in Gay and Bisexual Men and Transgender People PART III: Cancer Survivorship -- What are the numbers? Epidemiology of Cancer in the LGBT community -- Breast Cancer in Lesbian and Bisexual Women -- Gay Men and Prostate Cancer: Opportunities To Improve HRQOL and Access To Care -- HIV-Associated Cancers -- Provider-Patient Issues for the LGBT Cancer Patient -- Needs of LGBT Cancer Survivors -- Challenges and Recommended Solutions for Receiving Appropriate End-Of-Life-Care for Lesbians, Gay, Bisexual and Transgender Patients Diagnosed with Cancer with a Life-Limiting Prognosis -- IV Cancer at the Intersection -- Cancer Care needs of Transgender, Transsexual and other Gender Nonconforming Populations -- The Needs of Racial/Ethnic LGBT Individuals across the Cancer Care Continuum -- V Healthcare Policy and LGBT Health -- Policy and its Impact on LGBT Cancer -- Current policy and research on cancer in LGBT communities internationally -- The Challenges Remain: Needed Next Steps in Alleviating the Burden of Cancer in the LGBT Community -- Contributors -- Index.
520 $a Cancer and the LGBT Community: Unique Perspectives from Risk to Survivorship covers the scope of current knowledge of cancer in the LGBT community across the entire cancer continuum, from understanding risk and prevention strategies in LGBT groups, across issues of diagnosis and treatment of LGBT patients, to unique aspects of survivorship and death and dying in these communities. Each chapter includes an in depth analysis of the state of the science, discusses the many remaining challenges and unanswered questions, and makes recommendations for research, policy and programmatic strategies required to address these. Focus is also placed on the diversity of the LGBT communities. Issues that are unique to cancer in LGBT populations are addressed including the social, economic, and cultural factors that affect cancer risk behaviors, barriers to screening, utilization of health care services, and legislation that directly impacts the health care of LGBT patients, healthcare settings that are heterosexist, and unique aspects of patient-provider relationships such as disclosure of sexual orientation, and the need for inclusion of expanded definition of family to include families of choice. The implications of policy change, its impact on healthcare for LGBT patients are highlighted, as are the remaining challenges that need to be addressed. A roadmap for LGBT cancer prevention, detection, diagnosis, survivorship, including treatment and end of life care is offered for future researchers, policy makers, advocates and health care providers.
650 0 $a Cancer $x Epidemiology. $3 832876
650 0 $a Sexual minorities $x Diseases. $3 2156176
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Biomedicine general. $3 890966
650 2 4 $a Oncology. $3 751006
650 2 4 $a General Practice / Family Medicine. $3 893976
650 2 4 $a Quality of Life Research. $3 897157
650 2 4 $a Psychology Research. $3 1530112
700 1 $a Boehmer, Ulrike. $3 2156175
700 1 $a Elk, Ronit. $3 1962287
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-15057-4
950 $a Biomedical and Life Sciences (Springer-11642)